ArticleAmerican journal of cancer research2024

NRP1 overexpression potentially enhances osimertinib resistance in NSCLC via activation of the PI3K/AKT signaling pathway.

Yi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.